Johnson & Johnson Aktie 943981 / US4781601046
160.24
USD
0.22
USD
0.14%
01:58:57
NDN
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Orderbuch | Analysen | |||||
Historisch | Ausblick |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99.81 |
Vanguard Group, Inc. (Subfiler) | 9.07 |
SSgA Funds Management, Inc. | 5.47 |
State Street Corp. | 5.39 |
Vanguard Total Stock Market ETF | 3.11 |
BlackRock Fund Advisors | 2.76 |
Vanguard 500 Index Fund | 2.36 |
BlackRock Institutional Trust Co. NA | 2.23 |
Geode Capital Management LLC | 1.87 |
State Farm Investment Management Corp. | 1.22 |
Fidelity 500 Index Fund | 1.12 |
T. Rowe Price Associates, Inc. (Investment Management) | 1.03 |
Norges Bank (13F) | 1.00 |
Government Pension Fund - Global (The) | 0.98 |
Wellington Management Co. LLP | 0.97 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 135'100 | 132'200 | 134'500 | 141'700 | 152'700 |
Umsatz pro Mitarbeiter in Mio. EUR | 0.60 | 0.62 | 0.61 | 0.66 | 0.62 |
Bilanz (in Mio. EUR) - Aktiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 46'033 | 45'274 | 51'237 | 60'979 | 55'294 |
Summe Anlagevermögen | 90'232 | 88'152 | 99'644 | 108'774 | 117'763 |
Summe Aktiva | 152'954 | 157'728 | 174'894 | 182'018 | 187'378 |
Bilanz (in Mio. EUR) - Passiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 30'480 | 28'681 | 36'366 | 34'751 | 40'959 |
Summe Fremdkapital | 93'202 | 98'257 | 111'616 | 107'995 | 110'574 |
Summe Eigenkapital | 59'752 | 59'471 | 63'278 | 74'023 | 76'804 |
Summe Passiva | 152'954 | 157'728 | 174'894 | 182'018 | 187'378 |
Adresse
One Johnson & Johnson Plaza, 08933 New Brunswick | |
Telefon | +1 (732) 524-0400 |
URL | http://www.jnj.com |
Management
A. Eugene Washington
Independent Director |
Ahmet Tezel
Global Head-Research & Development |
Anne M. Mulcahy
Lead Independent Director |
Ashley A. McEvoy
Executive VP & Worldwide Chairman-MedTech |
Bernardo Tavares
Chief Information Officer |
D. Scott Davis
Independent Director |
Darius Adamczyk
Independent Director |
Elizabeth Forminard
Executive Vice President & General Counsel |
Frederic H. Moll
Chief Development Officer |
Hubert Joly
Independent Director |
James D. Swanson
Global Chief Information Officer & Executive VP |
Jennifer A. Doudna
Independent Director |
Jennifer L. Taubert
EVP & Worldwide Chairman-Pharmaceuticals |
Jessica Moore
Vice President-Investor Relations |
Joanne Waldstreicher
Chief Medical Officer |
Joaquin Duato
Chairman & Chief Executive Officer |
Jonathan Sheh
Director-Workplace Experience |
Joseph J. Wolk
Chief Financial Officer & Executive Vice President |
Kathleen M. Widmer
Group Chairman-Consumer North America |
Kathryn E. Wengel
Chief Technical Operations & Risk Officer |
Lisa Paley
Vice President-US Sales |
Lisa Romanko
Senior Director-Investor Relations |
Marc Larkins
Secretary |
Marillyn A. Hewson
Independent Director |
Mark Alan Weinberger
Independent Director |
Mark B. McClellan
Independent Director |
Mary C. Beckerle
Independent Director |
Matthew Stuckley
Senior Finance Director |
Meredith Stevens
Vice President |
Michael Bzdak
Global Dir-Employee Engagement-Global Cmnty Impact |
Nadja Y. West
Independent Director |
Neil Ackerman
Head-Innovation, Global Supply & Transformation |
Paul Ruh
Chief Financial Officer-Consumer Health |
Paula A. Johnson
Independent Director |
Peter M. Fasolo
Chief Human Resources Officer & Executive VP |
Robert J. Decker
Chief Accounting Officer & Controller |
Ronald A. Kapusta
Chief Accounting Officer & Controller |
Scott White
Company Group Chairman |
Thomas J. Spellman
Secretary |
Warren Foust
President-Surgical Vision |
William E. Cohn
Vice President-Medical Devices |